Qiuzi Zhao1, Ping Du2, Xiaoyong Wang2, Mengqian Huang1, Ling-Dong Sun2, Tao Wang1, Zhiyun Wang3. 1. School of Life Sciences, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, China. 2. Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Rare Earth Materials Chemistry and Applications, PKU-HKU Joint Laboratory in Rare Earth Materials and Bioinorganic Chemistry, College of Chemistry and Molecular Engineering, Peking University, 202 Chengfu Road, Haidian District, Beijing 100871, China. 3. School of Environmental Science and Engineering, 135 Yaguang Road, Jinnan District, Tianjin 300350, China.
Abstract
Influenza A virus (IAV) poses a significant threat to human health, which calls for the development of efficient detection methods. The present study constructed a fluorescence resonance energy transfer (FRET) system based on novel fluorescent probes and graphene oxide (GO) for detecting H5N1 IAV hemagglutinin (HA). Here, we synthesized small (sub-20 nm) sandwich-structured upconversion nanoparticles (UCNPs) (SWUCNPs for short) with a high energy transfer efficiency, which allows for controlling the emitter in a thin shell. The π-π stacking interaction between the aptamer and GO shortens the distance between the fluorescent probe and the receptor, thereby realizing fluorescence resonance energy transfer (FRET). When HA is present, the aptamer enables changes in their conformations and move away from GO surface. Fluorescence signals display a linear relationship between HA quantitation in the range of 0.1-15 ng mL-1 and a limit of detection (LOD) of 60.9 pg mL-1. The aptasensor was also applicable in human serum samples with a linear range from 0.2 to 12 ng mL-1 and a limit of detection of 114.7 pg mL-1. This strategy suggested the promising prospect of the aptasensor in clinical applications because of the excellent sensing performance and sensitivity. This strategy may be promising for vitro diagnostics and provides new insights into the functioning of the SWUCNPs system.
Influenza A virus (IAV) poses a significant threat to human health, which calls for the development of efficient detection methods. The present study constructed a fluorescence resonance energy transfer (FRET) system based on novel fluorescent probes and graphene oxide (GO) for detecting H5N1IAV hemagglutinin (HA). Here, we synthesized small (sub-20 nm) sandwich-structured upconversion nanoparticles (UCNPs) (SWUCNPs for short) with a high energy transfer efficiency, which allows for controlling the emitter in a thin shell. The π-π stacking interaction between the aptamer and GO shortens the distance between the fluorescent probe and the receptor, thereby realizing fluorescence resonance energy transfer (FRET). When HA is present, the aptamer enables changes in their conformations and move away from GO surface. Fluorescence signals display a linear relationship between HA quantitation in the range of 0.1-15 ng mL-1 and a limit of detection (LOD) of 60.9 pg mL-1. The aptasensor was also applicable in human serum samples with a linear range from 0.2 to 12 ng mL-1 and a limit of detection of 114.7 pg mL-1. This strategy suggested the promising prospect of the aptasensor in clinical applications because of the excellent sensing performance and sensitivity. This strategy may be promising for vitro diagnostics and provides new insights into the functioning of the SWUCNPs system.
Influenza
A viruses (IAVs) belong to the family of Orthomyxoviridae
and are spherical in shape of about 80–120 nm diameter.[1] The subtypes of influenza A viruses are further
classified according to the antigenicity of surface glycoproteins
hemagglutinin (HA) and neuraminidase (NA).[2] HA exists as trimeric spikes on the viral membrane, mediating the
attachment of influenza virus to host cells containing sialic acid
and facilitating viral infection.[3] The
highly conserved areas of HA are crucial for viral function and replication,
which is suitable as the detection target for H5N1 diagnosis.[4] The infection of influenza A virus has to represent
a grave threat to public health as well as the global economy. Since
2003, the avian influenza A (H5N1) virus has caused 455 deaths of
861 peopleinfected.[5] Rapid and sensitive
detection for the diagnosis of H5N1infection are essential for disease
control. At present, the traditional methods of detection and diagnosis
include viral culturing, serology, and viral nucleic acid detection
techniques.[6] Viral culturing requires professionally
trained technicians, as well as complex and expensive equipment.[7] Enzyme-linked immunosorbent assay (ELISA) is
an antibody-based conventional assay method; however, ELISA has a
relatively low sensitivity and complicated operation steps.[8] The polymerase chain reaction (PCR)-based viral
nucleic acid detection requires professionally trained personnel,
and this detection method is prone to cross-contamination and false-positive
results. Nonspecific amplification is actually a real problem that
influences the accuracy of PCR methods.[9]Fluorescence resonance energy transfer (FRET) is distance-dependent
energy transfer between two fluorophores and shows particular advantages
of a separation-free step.[10,11] Lanthanide-doped upconversion
nanoparticles (UCNPs) can be excited with near-infrared (NIR) light,[12] avoiding the influence of biological background
fluorescence. Its advantages are significant Stokes shift, narrow
emission spectrum, long lifetime, etc. Compared with downconversion
conventional fluorescent probes, UCNPs reduce the background of autofluorescence
and enhances light stability, significantly improving the signal-to-noise
ratio in biological detection based on fluorescent labels.[13−18] Consequently, UCNPs hold great promise for biodetection based on
fluorescence labeling. It is well known that the efficiency of FRET
is highly dependent on the distance between the donor and the acceptor,
and nonradiative energy transfer is usually effective within a distance
of 10 nm.[19] The small-size UCNP doped with
lanthanide ions is used to shorten the distance between the donor
and the acceptor. However, the small size of UCNP will reduce the
efficiency of upconversion luminescence (UCL), which is susceptible
to quenching from surroundings.[20−22] To effectively improve the energy
transmission efficiency, we adopt a layer-by-layer seed-mediated shell
growth strategy to fabricate a sandwich-structured UCNPs.[23] This strategy allows the emission center to
be located in the sandwich layer close to the surface of the UCNPs,
which enables most emitting ions to be confined in a thin layer near,
thereby ensuring improved signal intensity. As such, it would be able
to achieve higher detection sensitivity of HA.It has been proven
that graphene oxide (GO) is an oxidized single-atom-thick,
two-dimensional carbon material.[24] A few
reports have indicated that GO can bind with single-stranded DNA (such
as aptamer) via a π–π stacking interaction between
the carbon cycle and single-stranded DNA. As a fluorescent acceptor,
GO has a high solubility in an aqueous solution, a large specific
surface area, and a highly efficient quenching ability, making it
suitable as a high-efficiency quencher of UCNP.[25,26] This FRET design eliminates the need for a covalent label and shortens
the total assay time, which inspired the design of novel FRET sensors
based on GO and the aptamer.[27,28]Aptamers are
single-stranded DNA or RNA, which are selected through
the systematic evolution of ligands by the exponential enrichment
(SELEX) technique.[29,30] Compared with antibodies, aptamers
are much smaller in size and have thermal and chemical stability and
flexible modification. The properties of high affinity and specificity
in binding targets make aptamers effective molecular elements for
biomedical detection.[31] Heretofore, aptamer-based
sensors have been widely used in the homogeneous determination of
biomolecules.[32−34]To date, various strategies based on the aptamer
for influenza
A virus A (IAV) detection have been developed. However, few HA detection
methods have been developed based on UCNPs and GO. This study aimed
to test a new type of UCNPs to establish a highly selective and sensitive
fluorescent probe for in vitro assays. In this paper, combining the
advantage of GO and sandwich-structured UCNPs (SWUCNPs) and NaGdF4@NaYF4:Yb,Er@NaYF4 UCNPs as energy donors
and GO as energy receptors are designed as a FRET system for the sensitive
detection of H5N1 HA. The HA aptamer-modified SWUCNPs could be brought
in close proximity to the GO surface based on the π–π
stacking interaction between the aptamer and GO, and then, FRET-induced
fluorescence quenching can be observed. In the presence of HA of the
H5N1 virus, the formation of the aptamer–HA complex restrained
the interaction between the aptamer and GO, which inhibited the FRET
process and resulted in the restoration of fluorescence. Based on
the SWUCNPs as the energy donor by conjugating the aptamers, a high-sensitivity
platform for FRET-based applications was designed. The proposed concept
and strategy provides a versatile platform for probing the upconversion
emission-based aptasensor for practical applications.
Results and Discussion
Principle of the SWUCNP-FRET-Based
Aptasensor
for HA of the H5N1 Virus
The aptasensor strategy for HA detection
was based on FRET from modified SWUCNPs to GO, as briefly depicted
in Figure . The amino-modified
H5N1 HA aptamers were attached to the polyacrylic acid (PAA)-functionalized
SWUCNPs by condensation, which can be employed as probes for sensitive
and selective detection of HA. Moreover, a system of this type can
be implemented by employing a single mixing step. In the absence of
H5N1 HA, the distance between SWUCNPs and GO was shortened to <10
nm because the aptamer-modified UCNPs (UCNP-Apt for short, 0.05 mg
mL–1) can be brought in close proximity to the GO
surface based on the strong π–π stacking effect.
Meanwhile, the resonance energy transfer process enables quenching
of upconversion luminescence due to their highly overlapped spectrum.
In contrast, in the presence of HA, aptamers preferentially bind to
HA, which leads to changes in the G-quadruplex structure,[2,35−37] thereby promoting the separation of the donor and
the acceptor, and the upconversion fluorescence is regained.[38] Substitution of UCNPs with FAM dye shows the
feasibility of using the H5N1 HA aptamer as the recognition probes(Figure S1).Aptamer binding triggers a conformational
change, restoring the prequenched fluorescence signal.
Figure 1
Schematic illustration
to detect HA of influenza based on the FRET
method.
Schematic illustration
to detect HA of influenza based on the FRET
method.
Characterization
of the Sandwich-Structured
UCNPs
To protect the emitters from environmental quenching
and improve quantum yield and brightness, we synthesized the sandwich-structured
NaGdF4@NaYF4:Yb,Er@NaYF4 with an
average diameter of ∼17.7 nm (Figure c) using a layer-by-layer seed-mediated shell
growth strategy. The inert shell thickness was a compromise between
passivating the structure and therefore improving the quantum yield
and brightness while maintaining a small nanoparticle size. NaGdF4 nanocrystals were first synthesized as the core and subsequently
coated with the NaYF4:Yb,Er shell through epitaxial growth.
To protect the emitting ions from environmental quenching, another
NaYF4 shell was further deposited on the surface of the
inner shell to form the SWUCNPs. Transmission electron microscopy
(TEM) images of the as-synthesized nanoparticles (Figure a–c) illustrate the
size evolution of the materials, from the ∼10.4 nm NaYF4 cores to the ∼12.8 nm NaGdF4@NaYF4:Yb,Er core–shell particles and further to the ∼17.7
nm NaGdF4@NaYF4:Yb,Er@NaYF4 sandwich
structure. According to the size histograms obtained from the large-area
TEM images, the size distributions of all of these materials are quite
narrow (σ < 4%), indicating the fine control of the material
morphology by the growth pathway. Legible lattice fringes of 0.52
nm in the high-resolution TEM (HRTEM) image (Figure d) are correlated with the (100) plane of
hexagonal NaYF4, which is also verified by the selected area electron
diffraction (SAED) pattern result (Figure e). The X-ray diffraction (XRD) patterns
(Figure f) indicate
that the NaGdF4@NaYF4:Yb,Er@NaYF4 sandwich structure was hexagonal in-phase (JCPDS 27-0699). All of
the results demonstrate the successful synthesis of SWUCNPs. As displayed
in Figure g, the protecting
layer significantly strengthens the fluorescence intensity in comparison
to the core–inner shell material.
Figure 2
TEM images of (a) NaGdF4 core, (b) NaGdF4@NaYF4:Yb,Er, core–inner
shell structure, (c) NaGdF4@NaYF4:Yb,Er@NaYF4 sandwich structure.
(d) High-resolution TEM image and (e) SAED pattern of SWUCNPs. (f)
XRD patterns of the obtained nanoparticles. (g) Emission spectra of
NaGdF4@NaYF4:Yb,Er@NaYF4 and NaGdF4@NaYF4:Yb,Er UCNPs.
TEM images of (a) NaGdF4 core, (b) NaGdF4@NaYF4:Yb,Er, core–inner
shell structure, (c) NaGdF4@NaYF4:Yb,Er@NaYF4 sandwich structure.
(d) High-resolution TEM image and (e) SAED pattern of SWUCNPs. (f)
XRD patterns of the obtained nanoparticles. (g) Emission spectra of
NaGdF4@NaYF4:Yb,Er@NaYF4 and NaGdF4@NaYF4:Yb,Er UCNPs.
Characterization of PAA-Coated UCNPs and GO
A modified two-step ligand-exchange route, NOBF4-PAA
treatment, was also adopted to transfer the oleic acid (OA)-capped
UCNPs to water. To realize the above design, PAA-coated upconverting
nanoparticles were first prepared by a modified two-step ligand-exchange
route, NOBF4-PAA treatment, to enhance the dispersibility
in water. The carboxyl group of PAA on the surface of UCNPs could
further conjugate with other biomolecules such as aptamers. The existence
of PAA molecules on the surface of UCNPs is confirmed by Fourier transform
infrared (FT-IR) spectra (Figure a); in the case of OA-UCNPs, the peaks at 2926 (C–H
stretching vibration), 1562 (C=O stretching vibration), and
1465 cm–1 (C–O stretching vibration) demonstrate
the presence of OA molecules. After the two-step ligand-exchange route,
the bands centered at 1719 and 1571 cm–1 suggest
an increased quantity of −COOH groups on the particle surface.
Furthermore, the shoulder band at 2926 cm–1 associated
with the characteristic absorption of OA is also obviously weakened,
demonstrating that OA molecules had been efficiently substituted by
PAA. After ligand exchange, the TEM image of PAA-capped SWUCNPs (Figure c) shows that the
nanoparticles were well dispersed in water and demonstrated good stability
and uniform size. To explore the possible mechanisms behind energy
transfer between UCNP and GO, we sought to examine the upconversion
emission spectrum of UCNPs and the UV–visible absorption spectrum
of GO (Figure b).
The as-synthesized SWUCNPs exhibited maximum fluorescence at 541 nm.
Moreover, there is a good overlap between the emission and absorption
spectra of GO (approximately 300–700 nm), thus facilitating
energy transfer from UCNPs to GO.
Figure 3
(a) FT-IR spectra of SWUCNPs capped with
OA molecules and PAA molecules.
(b) Upconversion fluorescence spectra of SWUCNPs and the UV–vis
absorption spectra of GO. (c) TEM images of PAA-capped SWUCNPs and
(d) complex of GO (0.1 mg mL–1) and UCNP-Apt (0.05
mg mL–1).
(a) FT-IR spectra of SWUCNPs capped with
OA molecules and PAA molecules.
(b) Upconversion fluorescence spectra of SWUCNPs and the UV–vis
absorption spectra of GO. (c) TEM images of PAA-capped SWUCNPs and
(d) complex of GO (0.1 mg mL–1) and UCNP-Apt (0.05
mg mL–1).
Characterization of the UCNP-Aptamer Nanoprobe
As shown in Figure a, there was one peak at 260 nm in the UV–vis spectrum of
the aptamer. A new absorption peak appeared at 260 nm for UCNP-PAA
after aptamer conjugation through 3-(3-dimethylaminopropyl)-carbodiimide
hydrochloride (EDC) and N-hydroxysulfosuccinimide
(sulfo-NHS) activation, verifying the successful conjugation. We also
analyzed the sizes of UCNP-PAA and the UCNP-PAA-NH2 aptamer
by dynamic light scattering (DLS). After covalent coupling, the particle
size of nanoparticles turned 32.7 to 68.1 nm (Figure b). From Figure c, It could be seen that PAA-modified UCNPs
were negatively charged. After the reaction, the ζ-potential
changed from −39 to −13mV, indicating that UCNPs conjugated
with the aptamer through coupling reaction. After incubation with
GO, the complexes were formed by a π–π stacking
effect between the interaction of aptamer and the sp2 atoms
of GO. As depicted in Figure d, there are intermolecular π–π stacking
interactions between UCNP-Apt (0.05 ng mL–1) and
GO sheets. Since the aptamer affinity to the protein is much higher
than that of the aptamer and GO (Figure S2), the conformational change of the aptamer makes a difference in
the nanoparticle density.
Figure 4
(a) UV–vis absorption spectra of UCNP
and UCNP-Apt conjugates.
(b) DLS and (c) ζ-potential of UCNP-PAA and UCNP-PAA-NH2-aptamer. (d) Fluorescence intensity at 541 nm of UCNP-Apt
(a–c) and UCNP-rDNA (d–f) under different circumstances.
The concentrations of UCNP-Apt, GO, and HA were 0.05 mg mL–1, 150 μg mL–1, and 10 ng mL–1, respectively. Error bars represented the standard deviation (SD)
of three parallel tests.
(a) UV–vis absorption spectra of UCNP
and UCNP-Apt conjugates.
(b) DLS and (c) ζ-potential of UCNP-PAA and UCNP-PAA-NH2-aptamer. (d) Fluorescence intensity at 541 nm of UCNP-Apt
(a–c) and UCNP-rDNA (d–f) under different circumstances.
The concentrations of UCNP-Apt, GO, and HA were 0.05 mg mL–1, 150 μg mL–1, and 10 ng mL–1, respectively. Error bars represented the standard deviation (SD)
of three parallel tests.To verify the specific
recognition of aptamers and HA, a control
experiment was also performed using random ssDNA (rDNA) instead of
the H5N1 aptamer (Figure d). The results displayed that UCNP-rDNA could not be released
from GO by HA in this experimental condition. The results of UV–vis
absorption, TEM, DLS, and ζ-potential proved that UCNPs conjugated
with the aptamer through a coupling reaction and UCNP-Apt could recognize
HA.
Optimization of the FRET System
To
investigate the energy transfer between the donor–acceptor
pair, we fixed the concentration of UCNP-Apt (0.05 mg mL–1) and changed the concentration of GO, wherein F0 and F represent the upconversion fluorescence
intensities of the UCNP-Apt–GO complex in the absence and presence
of HA, respectively. As we have seen from Figure a, the quenching efficiency was strongly
dependent on the GO concentration. Excessive GO concentration might
yield unspecific HA binding, which is not conducive to the improvement
of sensitivity. We tend to choose 100 μg mL–1 as a balanced pattern. Figure b shows the effect of different concentrations of GO
on the fluorescence intensity of UCNP-Apt (0.05 mg mL–1) in the presence (Figure b, F) and absence (Figure b, F0) of HA.
To preclude the nonspecific adsorption and make the fluorescent aptasensor
more sensitive, a GO concentration of 100 μg mL–1 was selected for subsequent experiments. To ensure reaching the
quenching equilibrium and getting stable fluorescence signals (Figure c), the UCNP-Apt
(0.05 mg mL–1) displayed a slow decrease in the
luminescence intensity after 30 min of incubation with HA (10 ng mL–1) at 37 °C. Thus, the optimal incubation time
was determined to be 30 min. The recovery of the fluorescence signal
depends on whether the aptamer can maintain a specific configuration.
Different buffers, pH values, and metal ions often affect correct
aptamer folding, so we optimized the detection conditions of the FRET
system based on aptamers. Figure d showed the results of buffer tests, which demonstrate
that borate-buffered saline (BBS) is the most suitable for FRET detection.
The folding of the aptamer is affected by the surrounding buffer conditions
(such as pH, ionic strength, or the presence of specific ions). We
speculate that the salt content and pH of BBS are not easily affected
by storage time and temperature, which is conducive to the stability
of the aptamer configuration. Simultaneously, the composition of the
buffer solution does not coordinate with the rare-earth ions, which
ensures the stability of the probe function. Then, the effect of pH
on upconversion fluorescence was studied. As shown in Figure e, during the range of 6.6–8.6
BBS, the response reached the maximum when the pH was 7.8. Thus, BBS
with a pH of 7.8 was used as the buffer in the following study. In
addition, the G-quadruplex secondary structure of the aptamer was
normally stable under monovalent cation (K+) conditions,
as shown in Figure f; KCl concentrations (0–10 mM) in borate buffer were investigated,
and KCl at 5 mM in borate buffer was selected as the working ionic
strength condition.
Figure 5
(a) Fluorescence intensity rate (F/F0) of UCNP-Apt (0.05 mg mL–1) by 10
ng mL–1 HA with various concentrations of graphene
oxide (excitation wavelength 980 nm). (b) Effect of GO concentration
on the fluorescence intensity of UCNP-Apt in the presence (F) and absence (F0) of 10 ng
mL–1 HA. (c) Time dependence of the fluorescence
quenching degree with UCNP-Apt (0.05 mg mL–1) and
100 μg mL–1 GO. All experiments were performed
in borate buffer (10 mM, 5 mM KCl, pH 7.8) under excitation at 980
nm. (d) Quenching using various reaction buffers (the concentration
of buffer solutions is 20 mM with the same pH). (e) pH dependence
of the fluorescence intensity. (f) Quenching efficiency with various
concentrations of KCl in borate buffer.
(a) Fluorescence intensity rate (F/F0) of UCNP-Apt (0.05 mg mL–1) by 10
ng mL–1 HA with various concentrations of graphene
oxide (excitation wavelength 980 nm). (b) Effect of GO concentration
on the fluorescence intensity of UCNP-Apt in the presence (F) and absence (F0) of 10 ng
mL–1 HA. (c) Time dependence of the fluorescence
quenching degree with UCNP-Apt (0.05 mg mL–1) and
100 μg mL–1 GO. All experiments were performed
in borate buffer (10 mM, 5 mM KCl, pH 7.8) under excitation at 980
nm. (d) Quenching using various reaction buffers (the concentration
of buffer solutions is 20 mM with the same pH). (e) pH dependence
of the fluorescence intensity. (f) Quenching efficiency with various
concentrations of KCl in borate buffer.
HA of H5N1 Virus Detection with the FRET System
Under the optimum conditions described above, the FRET system was
established for quantitative analysis. When HA interacts with the
UCNP-Apt system, the aptamer preferentially bound to target HA, which
leads to changes in the formation of aptamers. Therefore, the π–π
stacking interaction between the aptamer and GO was weakened and parts
of luminescence of UCNPs were reserved. In this condition, the energy
donor and acceptor have separated from each other. Therefore, the
FRET process was inhibited and the fluorescence of UCNPs recovered
accordingly. As shown in Figure a, increasing the concentration of HA resulted in increasing
degrees of fluorescence restoration. Under optimal conditions, the
logarithm of HA concentration was proportional to the relative intensity
[(F – F0)/F0]. Figure b shows that with the increasing number of HA from
0 to 30 ng mL–1, a significant increase in the intensity
at 541 nm was observed accordingly. Besides, a linear relationship
was obtained between the increasing fluorescence intensity of UCNPs
and the logarithm of HA concentration in the range from 0.1 to 15
ng mL–1 (Figure b). The regression equation could be represented by Y = 1.005 log(X) + 0.9611, with a reliable
correlation coefficient R2 = 0.9925. In
particular, the limit of detection (LOD) was estimated to be 60.9
pg mL–1 (S/N =
3). The result demonstrates that this proposed UCNP-FRET system was
a promising approach for the highly sensitive detection of H5N1 HA
because it was a homogeneous and straightforward procedure without
any separation or repeated reagent addition.
Figure 6
(a) Upconversion emission
spectra of the UCNP aptasensor in the
presence of various concentrations of H5N1 HA (0, 0.1, 0.2, 0.4, 1,
2, 4, 8, 10, 15, 20, 25, 30 ng mL–1) under optimal
experimental conditions, where F0 represents
the fluorescence intensity of the UCNP-Apt–GO complex (0.05
mg mL–1 UCNP-Apt and 0.1 mg mL–1 GO) and F is the fluorescence intensity of the
complex plus different concentrations of HA. (b) Relationship between
relative fluorescence intensity (F – F0)/F0 at 541 nm
against the H5N1 HA concentration. Inset: linear part of the plot
ranging from 0.01 to 15 ng mL–1 in borate buffer.
(c) Specific selectivity evaluation of the proposed method for HA
(20 ng mL–1) against other proteins (100 ng mL–1). (d) Relationship curve of relative fluorescence
intensity for added standard HA from human serum samples. It shows
the linear response with HA concentrations from 0.2 to 12 ng mL–1, under the experimental conditions the same as an
aqueous buffer. Error bars: SD, n = 3.
(a) Upconversion emission
spectra of the UCNP aptasensor in the
presence of various concentrations of H5N1 HA (0, 0.1, 0.2, 0.4, 1,
2, 4, 8, 10, 15, 20, 25, 30 ng mL–1) under optimal
experimental conditions, where F0 represents
the fluorescence intensity of the UCNP-Apt–GO complex (0.05
mg mL–1 UCNP-Apt and 0.1 mg mL–1 GO) and F is the fluorescence intensity of the
complex plus different concentrations of HA. (b) Relationship between
relative fluorescence intensity (F – F0)/F0 at 541 nm
against the H5N1 HA concentration. Inset: linear part of the plot
ranging from 0.01 to 15 ng mL–1 in borate buffer.
(c) Specific selectivity evaluation of the proposed method for HA
(20 ng mL–1) against other proteins (100 ng mL–1). (d) Relationship curve of relative fluorescence
intensity for added standard HA from human serum samples. It shows
the linear response with HA concentrations from 0.2 to 12 ng mL–1, under the experimental conditions the same as an
aqueous buffer. Error bars: SD, n = 3.
Specificity for H5N1 HA Detection
To assess the specificity of the proposed aptasensor for HA detection,
some abundant proteins in blood or analogous proteins including humanserum albumin (HSA), bovine serum albumin (BSA), thrombin, and immunoglobulin
G (IgG) were introduced individually into the aptasensor instead of
HA in the borate buffer. Different proteins were taken in a concentration
of 100 ng mL–1, 5 folds higher than that of HA (20
ng mL–1) under identical experimental conditions.
As shown in Figure c, none of these species caused a significant recovery of the fluorescence
intensity of UNCPs and the fluorescence intensity of HA was eight
times higher than that of other controls. Thus, the results above
vividly indicated that the designed fluorescent aptamer sensor is
highly specific to HA.
Detection of the HA Protein
in Human Serum
Serum is a known complicated biological matrix
containing various
biomolecules that tend to increase autofluorescence and scattering
light in optical sensing. To investigate the potential application
of this method, tests for HA in human serum were performed by spiking
the samples with a series of predetermined amounts of HA. Figure d shows the linear
relationship between the fluorescence changes (F – F0)/F0 and the logarithm
of HA concentration. For detection in the serum sample, the linear
relationship was observed in the range from 0.2 to 12 ng mL–1, which was a little different from that in aqueous buffer. The linear
equation was Y = 1.046 log(X) +
0.8723 with a LOD as low as 114.7 pg mL–1 (S/N = 3, n = 9). Figure S3 shows the corresponding fluorescence
spectrum. Meanwhile, the applicability of the sensor for real sample
analysis was investigated by employing the sensor to analyze these
serum samples. The recovery test of different concentrations of HA
in serum samples was determined using this sensor. The recovery of
HA in three spiked serum samples and the relative standard deviation
(RSD) levels (n = 3) are presented in Table . The excellent recoveries from
95.26 to 105.12% indicate that the designed method possesses reliable
accuracy for H5N1 HA detection. This finding indicates that the approach
has the potential for practical applications in the early diagnosis
of the HA protein. As shown in Figure S3, the HA concentration measured by the detection platform is consistent
with the ELISA method (R2 = 0.996). To
verify the stability of the UCNPs, we measured the fluorescence intensity
within 15 days and compared the interbatch accuracy in samples. As
shown in Figure S4, the results are in
line with this expectation. To further investigate the stability of
this method, we monitored the interassay variation of five serum samples.
The interassay accuracy varied between 95.37 and 114.50%, while the
precision ranged between 2.21 and 9.78% RSD (Table S1). A comparison between the present HA of the H5N1 virus
biosensor and other biosensors reported is summarized in Table S2. It indicated that the developed SWUCNP-GO
aptasensor has acceptable sensitivity and advantages in selectivity
and simplicity of preparation. Remarkably, the detection limit of
other HA aptamer-based fluorescence biosensors was 33 times higher
than that of our method. Because of their near-infrared (NIR) excitation
nature that minimizes autofluorescence from serum samples and interference
from scattered light, this aptasensor shows reliable stability and
sensitivity in serum detection. The SWUCNP-based aptamer platform
combines the advantages of small size and reversible secondary structure
conformation of the aptamer, which provides favorable conditions for
constructing a highly sensitive homogenous immunoassay based on the
FRET system.
Table 1
Detection of the HA Protein in Serum
Samples of This Method
samples
volume of
addition (ng mL–1)
found ± SD (ng mL–1)
recovery
(%)
RSD (%) n = 3
1
2
2.10 ± 0.023
105.12
1.09
5
5.02 ± 0.42
100.46
8.36
10
10.17 ± 0.73
101.72
7.18
2
1.83 ± 0.012
95.26
0.66
2
5
5.23 ± 0.52
104.54
9.94
10
10.41 ±
0.33
104.11
3.17
2
1.90 ± 0.12
94.95
6.31
3
5
4.90 ± 0.39
97.92
7.96
10
10.16 ± 0.63
101.66
6.20
Conclusions
Aptamer-based
targeting offers a novel approach to construct convenient,
ultrasensitive, specific, and stable platforms for bioassays. Due
to the sandwich-structured UCNPs and the introduction of GO, the SWUCNP-GO
aptasensors exhibited high FRET efficiency. The virtue of the SWUCNPs
improved the signal-to-noise ratio and avoided background luminescence
through a process of generating visible light by a NIR versatile platform.
There was a good linear relationship between the fluorescence signal
and the HA concentrations of 0.1–15 ng mL–1 with a low limit of detection of 60.9 pg mL–1,
and a selective method was applicable for HA quantification in human
serum, which has practical application value in real sample detection.
In summary, the sensitivity of detection is due to the low background
luminescence of SWUCNPs and high specificity of the aptamer toward
the HA protein of IAV.
Materials and Methods
Materials
2-(N-morpholino)-ethanesulfonic
acid (MES) hydrate, 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic
acid (HEPES), Tris, 3-(3-dimethylaminopropyl)-carbodiimide hydrochloride
(EDC), and N-hydroxysulfosuccinimide (sulfo-NHS)
sodium salt were purchased from Sigma-Aldrich Chemical (St. Louis,
MO). Water (DNase and RNase free), HEPES, and Tris were from Beijing
Solarbio Science & Technology Co., Ltd. (China). Boric acid (H3BO3), sodium tetraborate decahydrate (Na2B4O7·10H2O), sodium chloride
(NaCl), and potassium chloride (KCl) were obtained from Beijing Chemical
Works (Beijing, China). Influenza A H5N1 HA protein was purchased
from Sino Biological Inc. (Beijing, China). Bovine serum albumin (BSA)
was from Sigma (St. Louis, MO), humanserum albumin (HSA) was purchased
from Linc-bio Science Co., Ltd. (Shanghai, China), and immunoglobin
G (IgG) was purchased from Yuduo Biotech Co., Ltd. (He-nan, China).
All chemicals were of analytical reagent grade and obtained from a
commercial source unless mentioned otherwise. Healthy human serum
samples were provided by the Chinese Academy of Inspection and Quarantine.
The composition of the buffer used for the experiment was reported
as BBS (100 mmol L–1 H3BO3, 20 mmol L–1 Na2B4O7·10H2O, 5 mM KCl, pH 7.8). NaCl, KCl, MgCl2, and other common metal salts used were obtained from Beijing
Chemical Works (Beijing, China). All chemicals were commercial products
and used as received without further purification. Milli-Q water (Z18.2
MΩ) was used to prepare all stock solutions and buffer solutions.
Amine-modified H5N1 HA aptamer[39] (5′-NH2-
TTGGGGTTATTTGGGAGGGCGGGGGTT-3′) was supplied by Sangon Biotechnology
Co., Ltd. (Shanghai, China).
Synthesis of Oleic Acid-Stabilized
SWUCNPs
Oleic acid (OA)-stabilized NaGdF4@NaYF4:Ln@NaYF4 SWUCNPs were synthesized according to
the seed-mediated method
developed previously.[40]In a typical
procedure, 1 mmol CF3COONa and 1 mmol (CF3COO)3Gd were added to a 100 mL three-necked flask containing 10
mmol OA, 10 mmol OM, and 20 mmol ODE. The slurry was heated to 110
°C to remove residual water and oxygen. Then, the mixture was
heated to 320 °C and kept for 15 min in a N2 atmosphere.
After that, an excess amount of ethanol was added to precipitate the
nanoparticles. Nanoparticles were dispersed in 10 mL of cyclohexane.
Five millilters of the as-prepared nanoparticle colloidal solution
(nominal 0.5 mmol) was added to precursors (0.5 mmol CF3COONa, 0.5 mmol Gd(CF3COO)3, and solvents (20
mmol OA and 20 mmol ODE)). Reaction conditions and after-treatments
are the same as aforementioned. The resulting NaGdF4 nanoparticles
were stocked in 10 mL of cyclohexane.Five millilters of the
hexagonal NaGdF4 solution, used
as seeds for epitaxial growth, was added to the precursors of the
shell (1 mmol CF3COONa and 0.78 mmol Y(CF3COO)3, 0.2 mmol (CF3COO)3Yb, and 0.02 mmol
(CF3COO)3Er) and solvents (20 mmol OA and 20
mmol ODE). Reaction conditions and after-treatments were the same
as those in the first step to get NaGdF4@NaYF4:Yb,Er nanoparticles.Ten millilters of the as-prepared NaGdF4@NaYF4:Yb,Er colloidal solution (nominal 0.25 mmol)
was added to a 100
mL three-necked flask containing precursors (1 mmol CF3COONa, 1 mmol Y(CF3COO)3) and solvents (20
mmol OA and 20 mmol ODE). Reaction conditions and after-treatments
were the same as aforementioned. The final products were dispersed
in 5 mL of cyclohexane for further characterizations.
Preparation of Water-Dispersible Nanoparticles
Typically,
1 mL of colloidal solutions of oleate-capped nanoparticles
was dispersed in a mixture of cyclohexane and N,N-dimethylformamide (DMF) (10 mL, volume ratio 1:1). Then,
30 mg of NOBF4 was added to the system with vigorous stirring
for 30 min.[41] The oleate ligands left in
the cyclohexane phase, while the oleate-free nanoparticles transferred
to the DMF phase. Subsequently, the nanoparticles were collected by
centrifugation (12 000 rpm, 15 min) after adding an excess
amount of toluene. The nanoparticles were redispersed in 10 mL of
DMF containing 20 mg of polyacrylic acid (PAA, Mw = 1800, 50% saponification). The mixture was stirred overnight
to render PAA modification. Finally, the excess amount of acetone
was added to the solution to precipitate PAA-modified nanoparticles.
The hydrophilic nanoparticles were collected by centrifugation (12 000
rpm, 15 min) and dispersed in water for further experiments.
Surface Modification and Bioconjugation of
PAA-UCNPs with Aptamers
The amine-modified H5N1 HA aptamer
was covalently conjugated to PAA-SWUCPs following the standard EDC–NHS
conjugation protocol. Briefly, 2 mg of PAA-UCNPs was added to 2 mL
of MES buffer solution (10 mM, pH 5.6), and the aqueous solution was
sonicated for 10 min. Then, 0.4 mg of EDC and 0. 6 mg of sulfo-NHS
were added to the solution to activate the carboxyl groups on PAA.
The mixture was incubated at room temperature with gentle shaking
for 15 min.After centrifugation, the activated PAA-SWUCNPs
were washed with ultrapure water three times and then dispersed in
2 mL of borate buffer (10 mM, pH 7.8, 5 mM KCl) containing 2 nmol
amino-modified HA aptamer. The reaction lasted overnight at room temperature
with slow shaking. To block the excess NHS, 5 mg of Tris was added
to the reaction mixture. The SWUCNP-aptamer was obtained by centrifugation
at 8000 rpm, washed with ultrapure water three times, redispersed
in 2 mL of borate buffer solution (10 mM, pH 7.8, 5 mM KCl), and preserved
at 4 °C to keep its activity.
HA Detection
in Aqueous Solution and Human
Serum
For the sake of determining a suitable concentration
of GO to proceed the subsequent fluorescence recovery experiments,
different amounts of GO were separately incubated with a fixed amount
of UCNP-aptamer (0.05 mg mL–1) in borate buffer
(10 mM, pH 7.8, 5 mM KCl) for 25 min at room temperature. Afterward,
upconversion fluorescence measurements were carried out. In a typical
FRET assay process, various concentrations of HA were first mixed
with the SWUCNP-aptamer (0.05 mg mL–1) conjugates
in 10 mM borate buffer (pH 7.8, 5 mM KCl) and the mixture was incubated
at room temperature for 30 min. Afterward, graphene oxide was added
into the above mixtures with an ultimate concentration of 0.01 mg
mL–1 followed by incubation for 25 min. Finally,
the upconversion luminescence spectra of the final mixture were then
measured using an FLS fluorescence spectrometer with an external 980
nm laser. To verify the specificity of the above FRET aptasensor toward
HA, a series of interfering biomolecules including HSA, thrombin,
BSA, and IgG were added to the SWUCNP-aptamer/GO system in place of
HA following the same experimental procedures. For the detection in
serum samples, newly obtained serum 20 times diluted with borate buffer
was used as the assay medium and then the same assay procedure as
that in the aqueous solution was followed. Furthermore, the standard
addition method was adopted to determine the concentration of HA in
practical serum samples.
Instruments and Characterizations
The morphologies and sizes of UCNPs and GO were characterized by
transmission electron microscopy (TEM) (JEM-2010, Japan). Ambient
X-ray diffraction (XRD) patterns were recorded on a PANalytical X’Pert3
powder diffractometer using Cu Kα radiation (λ = 1.5406
Å). The UV–vis absorption measurements were carried out
using a UV–vis spectrophotometer (UV3600Plus, Shimadzu Scientific
Instruments Inc.). A Fourier transform infrared (FT-IR) absorption
spectrometer (Tensor 27, Bruker) was used to characterize the PAA-SWUCNPs.
The ζ-potential measurements were performed using a Zetasizer
Nano ZS instrument (Malvern Instruments, U.K.). The upconversion fluorescence
spectra were measured at 541 nm using an FLS980 steady-state and time-resolved
fluorescence spectrometer (Edinburgh Instruments) with an external
980 nm laser source.
Authors: Maciej Miarka; Andrzej Horban; Henryka Maliszewska; Przemysław Biliński; Wanda Prus-Kowalczuk Journal: Acta Biochim Pol Date: 2014-09-12 Impact factor: 2.149
Authors: Angang Dong; Xingchen Ye; Jun Chen; Yijin Kang; Thomas Gordon; James M Kikkawa; Christopher B Murray Journal: J Am Chem Soc Date: 2011-02-02 Impact factor: 15.419